title: Nafcillin-loaded PLGA nanoparticles for treatment of osteomyelitis.
abstract: The goal of this investigation is to develop poly(DL-lactide-co-glycolide) (PLGA) nanoparticles for the delivery of antibiotics such as nafcillin to osteoblasts. This is important in order to treat Staphylococcus aureus-mediated osteomyelitis. The latter is often chronic and highly resistant to antibiotics. Nafcillin (a penicillinase-resistant penicillin)-loaded nanoparticles were prepared by a single emulsion/solvent evaporation method. In vitro drug release studies were conducted in an incubator shaker at 37 degrees C in phosphate buffer saline. Drug loading and release were determined by UV-Vis spectroscopy. A viability study was conducted in S. aureus-infected mouse osteoblasts. In vitro release study showed an initial burst release and a second phase of slow release. Following 24 and 48 h of incubation, all formulations of nanoparticles loaded with nafcillin either killed or significantly reduced all of the intracellular bacteria. Our data demonstrate that effective killing of intracellular S. aureus is possible by treating the infected osteoblasts with nanoparticles loaded with nafcillin.
authors: Department of Chemistry, Polymer Nanotechnology Laboratory, Center for Optoelectronics, University of North Carolina, Charlotte, NC 28223, USA.
authors: Rajeev Raghavan
authors: RR
authors: Pillai
authors: Shankari N
authors: SN
authors: Somayaji
authors: Monica
authors: M
authors: Rabinovich
authors: Michael C
authors: MC
authors: Hudson
authors: Kenneth E
authors: KE
authors: Gonsalves
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000737:chemistry; D002478:Cells, Cultured; D004337:Drug Carriers / Q000008:administration & dosage / Q000737:chemistry*; D006801:Humans; D019344:Lactic Acid / Q000737:chemistry*; D051379:Mice; D009254:Nafcillin / Q000008:administration & dosage* / Q000737:chemistry; D053758:Nanoparticles / Q000008:administration & dosage / Q000737:chemistry* / Q000648:ultrastructure; D010006:Osteoblasts / Q000187:drug effects* / Q000382:microbiology*; D010019:Osteomyelitis / Q000188:drug therapy; D010316:Particle Size; D011100:Polyglycolic Acid / Q000737:chemistry*; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D013211:Staphylococcus aureus / Q000187:drug effects*
chemical_list: D000900:Anti-Bacterial Agents; D004337:Drug Carriers; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D019344:Lactic Acid; D009254:Nafcillin